NOT-CA-21-082: Notice of Correction to RFA-CA-20-031, Strengthening Institutional Capacity to Conduct Global Cancer Research in Low- and Middle-Income Countries (D43 Clinical Trial Not Allowed)

Notice of Correction to RFA-CA-20-031, Strengthening Institutional Capacity to Conduct Global Cancer Research in Low- and Middle-Income Countries (D43 Clinical Trial Not Allowed)

Notice Number:

NOT-CA-21-082

Key Dates

Release Date:

May 26, 2021

Related Announcements

RFA-CA-20-031 - Strengthening Institutional Capacity to Conduct Global Cancer Research in Low- and Middle-Income Countries (D43 Clinical Trial Not Allowed)

Issued by

National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to correct the Application Types Allowed for Funding Opportunity Announcement (FOA) RFA-CA-20-031, "Strengthening Institutional Capacity to Conduct Global Cancer Research in Low- and Middle-Income Countries (D43 Clinical Trial Not Allowed)".

The following section of RFA-CA-20-031 has been modified:

Currently Reads:

Part 2. Full Text of Announcement, Section II. Award Information

Application Types Allowed

New

Modified to Read (change shown in bold italics):

Part 2. Full Text of Announcement, Section II. Award Information

Application Types Allowed

New

Resubmission

All other aspects of the FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Scientific/Research Contact(s)

Sudha Sivaram, DrPH, MPH
National Cancer Institute (NCI)
Telephone: 240-276-5804
Email: [email protected]

Peer Review Contact(s)

Referral Officer
National Cancer Institute (NCI)
Telephone: 240-276-6390
Email: [email protected]

Financial/Grants Management Contact(s)

Dawn Mitchum
National Cancer Institute (NCI)
Telephone: 240-276-5699
Email: [email protected]